Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events is a research paper published in Journal of Cystic Fibrosis (2020). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UL1RR024153
National Institutes of Health
Grant: UL1TR000005
University of Pittsburgh
Grant: P30DK072482
University of Pittsburgh
Grant: U54TR001368
NCATS NIH HHS
Grant: U54 TR001356
National Institutes of Health
Grant: 3P30DK072482-03S3
UAB CF Research and Translation Core Center
National Institutes of Health
Grant: 8UL1TR000005-07
University of Pittsburgh Clinical and Translational Science Institute
National Institutes of Health
Grant: 3UL1RR024153-03S1
University of Pittsburgh Clinical and Translational Science Institute
Imperial College London
Manitoba Beekeepers' Association
Newcastle upon Tyne Hospitals NHS Foundation Trust
National Institute for Health and Care Research
National Institute for Health Research (NIHR)
FWCI
3.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals